Cargando…
Elevated Serum Neuropeptide FF Levels Are Associated with Cognitive Decline in Patients with Spinal Cord Injury
BACKGROUND: Spinal cord injury (SCI) has high incidence globally and is frequently accompanied by subsequent cognitive decline. Accurate early risk-categorization of SCI patients for cognitive decline using biomarkers can enable the timely application of appropriate neuroprotective measures and the...
Autores principales: | Sun, Shifei, Sun, Shilong, Meng, Yan, Shi, Bin, Chen, Yuanzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601828/ https://www.ncbi.nlm.nih.gov/pubmed/34804262 http://dx.doi.org/10.1155/2021/4549049 |
Ejemplares similares
-
Netrin-1: A Serum Marker Predicting Cognitive Impairment after Spinal Cord Injury
por: Meng, Yan, et al.
Publicado: (2022) -
Serum neutrophil gelatinase-associated lipocalin as a potential biomarker for cognitive decline in spinal cord injury
por: Zhang, Qinghao, et al.
Publicado: (2023) -
Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury
por: Chen, Yuanzhen, et al.
Publicado: (2020) -
Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation
por: Jhamandas, Jack H., et al.
Publicado: (2013) -
The hypothalamic neuropeptide FF network is impaired in hypertensive patients
por: Goncharuk, Valeri D, et al.
Publicado: (2014)